Successful treatment of chronic hepatitis C with triple therapy in an opioid agonist treatment program

Highlights • HCV triple therapy delivered on-site at an opiate agonist treatment program. • SVR rates nearly equivalent to outcomes of patients treated in registration trials. • SVR rates equivalent to other real-world studies which did not enroll PWUDs. • There was no association between illicit dr...

Ausführliche Beschreibung